Netmed Inc
OTC:NTME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Netmed Inc
Net Change in Cash
Netmed Inc
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Netmed Inc
OTC:NTME
|
Net Change in Cash
-$181k
|
CAGR 3-Years
23%
|
CAGR 5-Years
-78%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Change in Cash
$1.5B
|
CAGR 3-Years
87%
|
CAGR 5-Years
0%
|
CAGR 10-Years
27%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Net Change in Cash
-$119.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Net Change in Cash
$359m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Net Change in Cash
$906m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
24%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Change in Cash
$1.3B
|
CAGR 3-Years
66%
|
CAGR 5-Years
24%
|
CAGR 10-Years
28%
|
|
Netmed Inc
Glance View
NetMed, Inc. engages in the research and development of proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. The company is headquartered in Dublin Ohio, Ohio and currently employs 1 full-time employees. During the fiscal year ended December 31, 2001, the Company's sole business activity, through its majority-owned subsidiary, OxyNet, Inc., involved research and development activities associated with a proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. These activities were suspended effective December 31, 2001, pending efforts to locate a prospective licensee or development partner. The firm is continuing efforts, begun in 2001, to evaluate other business opportunities, which included preliminary investigation and due diligence. These efforts have not, in the judgment of the Company's management, produced an attractive merger or acquisition candidate. The firm is seeking a candidate with a proprietary product or service, which may be in the development stage, and offers an opportunity to realize these objectives.
See Also
What is Netmed Inc's Net Change in Cash?
Net Change in Cash
-181k
USD
Based on the financial report for Jun 30, 2002, Netmed Inc's Net Change in Cash amounts to -181k USD.
What is Netmed Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-78%
Over the last year, the Net Change in Cash growth was -20%. The average annual Net Change in Cash growth rates for Netmed Inc have been 23% over the past three years , -78% over the past five years .